Dose-dense (DO) AC followed by paclitaxel is associated with moderate, frequent anemia compared to sequential (S) and/or less DD treatment: Update by CALGB on breast cancer intergroup trial C9741 with ECOG, SWOG, & NCCTG Meeting Abstract


Authors: Citron, M. L.; Berry, D. A.; Cirrincione, C.; Livingston, R. B.; Gradishar, W.; Perez, E.; Muss, H.; Norton, L.; Winer, E.; Hudis, C.
Abstract Title: Dose-dense (DO) AC followed by paclitaxel is associated with moderate, frequent anemia compared to sequential (S) and/or less DD treatment: Update by CALGB on breast cancer intergroup trial C9741 with ECOG, SWOG, & NCCTG
Meeting Title: 41st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 23
Issue: 16 Suppl.
Meeting Dates: 2005 May 13-17
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2005-06-01
Start Page: 33S
Language: English
ACCESSION: WOS:000230326600130
PROVIDER: wos
DOI: 10.1200/jco.2005.23.16_suppl.620
Notes: --- - Meeting Abstract: 620 - 41st Annual Meeting of the American-Society-of-Clinical-Oncology - MAY 13-17, 2005 - Orlando, FL - S - Part 1 - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Clifford Hudis
    905 Hudis
  2. Larry Norton
    758 Norton